2017
DOI: 10.1016/j.radphyschem.2017.03.022
|View full text |Cite
|
Sign up to set email alerts
|

Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…PFMA-3 has been geared as a pulsed X-rays generator. The low-energy (up to 200 keV) X-rays produced by conversion on a brass target of the self-collimated electron beam generated by the device during the pinch phase are able to deliver a very high DR as shown in Table 1 where the main PFMA-3 features are summarized [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…PFMA-3 has been geared as a pulsed X-rays generator. The low-energy (up to 200 keV) X-rays produced by conversion on a brass target of the self-collimated electron beam generated by the device during the pinch phase are able to deliver a very high DR as shown in Table 1 where the main PFMA-3 features are summarized [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Plasma focus (PF) devices are investigated as intense soft x-ray (SXR) sources for their potential use in industrial applications such as medical applications [1][2][3][4][5][6], micro-machining [7,8], and lithography [9][10][11]. Therefore, the interest in the PF devices is growing in order to produce x-rays from these devices operated with various gases such as neon (Ne) and nitrogen (N).…”
Section: Introductionmentioning
confidence: 99%
“…of the University of Bologna to evaluate its possible uses in radiotherapy treatments thanks to the extremely high dose rate of up to 1 Gy/shots (each shots lasting 20-50 ns) that it is able to guarantee. To achieve this goal, the control, the analysis and the measurement of the delivered dose was performed as shown in Sumini et al (2017). The pre-clinical characterization of the effects of the very-high dose rate was analysed on in-vitro melanoma SK-MEL28 malignant cells cultures and the results compared with the ones coming from a traditional X-ray (XR) sources.…”
Section: Introductionmentioning
confidence: 99%